176 related articles for article (PubMed ID: 19492342)
1. Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier.
Tournier N; André P; Blondeel S; Rizzo-Padoin N; du Moulinet d'Hardemarre A; Declèves X; Scherrmann JM; Cisternino S
J Pharm Sci; 2009 Dec; 98(12):4650-60. PubMed ID: 19492342
[TBL] [Abstract][Full Text] [Related]
2. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
[TBL] [Abstract][Full Text] [Related]
3. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
4. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
[TBL] [Abstract][Full Text] [Related]
5. Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.
Tournier N; Valette H; Peyronneau MA; Saba W; Goutal S; Kuhnast B; Dollé F; Scherrmann JM; Cisternino S; Bottlaender M
J Nucl Med; 2011 Mar; 52(3):415-23. PubMed ID: 21321274
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
[TBL] [Abstract][Full Text] [Related]
7. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
[TBL] [Abstract][Full Text] [Related]
8. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
Schibli R; La Bella R; Alberto R; Garcia-Garayoa E; Ortner K; Abram U; Schubiger PA
Bioconjug Chem; 2000; 11(3):345-51. PubMed ID: 10821650
[TBL] [Abstract][Full Text] [Related]
9. Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).
Tournier N; Chevillard L; Megarbane B; Pirnay S; Scherrmann JM; Declèves X
Int J Neuropsychopharmacol; 2010 Aug; 13(7):905-15. PubMed ID: 19887017
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and comparative assessment of a labeled RGD peptide bearing two different ⁹⁹mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical.
Psimadas D; Fani M; Gourni E; Loudos G; Xanthopoulos S; Zikos C; Bouziotis P; Varvarigou AD
Bioorg Med Chem; 2012 Apr; 20(8):2549-57. PubMed ID: 22445386
[TBL] [Abstract][Full Text] [Related]
11. Biological evaluation of a technetium-99m-labeled integrated tropane-BAT and its piperidine congener as potential dopamine transporter imaging agents.
Kieffer DM; Vanbilloen HP; Cleynhens BJ; Terwinghe CY; Mortelmans L; Bormans GM; Verbruggen AM
Nucl Med Biol; 2006 Jan; 33(1):125-33. PubMed ID: 16459268
[TBL] [Abstract][Full Text] [Related]
12. Preparation and properties of 99mTc(CO)3+-labeled N,N-bis(2-pyridylmethyl)-4-aminobutyric acid.
Liu G; Dou S; He J; Vanderheyden JL; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2004; 15(6):1441-6. PubMed ID: 15546213
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine ((99m)Tc-ECC), the mono-acid derivative of (99m)tc-L,L-ethylenedicysteine.
Vanbilloen HP; Cleynhens BJ; Verbruggen AM
Nucl Med Biol; 2000 Feb; 27(2):207-14. PubMed ID: 10773551
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
[TBL] [Abstract][Full Text] [Related]
15. Preparation and biodistribution of 1-((2-methoxyphenyl) piperazine)ferrocenecarboxamide labeled with technetium-99m as a potential brain receptor imaging agent.
Saied NM; Mejri N; El Aissi R; Benoist E; Saidi M
Eur J Med Chem; 2015 Jun; 97():280-8. PubMed ID: 25993108
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biodistribution of a novel (99m)Tc nitrido dithiocarbamate complex containing aromatic group for cerebral imaging.
Zhang J; Lin X; Ren J; Liu J; Wang X
Appl Radiat Isot; 2010 Jan; 68(1):101-4. PubMed ID: 19796959
[TBL] [Abstract][Full Text] [Related]
17. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-labeled tricarbonyl his-CNA35 as an imaging agent for the detection of tumor vasculature.
Mees G; Dierckx R; Mertens K; Vermeire S; Van Steenkiste M; Reutelingsperger C; D'Asseler Y; Peremans K; Van Damme N; Van de Wiele C
J Nucl Med; 2012 Mar; 53(3):464-71. PubMed ID: 22331218
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
20. Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of
Giammei C; Balber T; Benčurová K; Cardinale J; Berroterán-Infante N; Brandt M; Jouini N; Hacker M; Mitterhauser M; Mindt TL
Molecules; 2020 Jun; 25(11):. PubMed ID: 32527027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]